CRL Dividend: Charles River Laboratories International Inc Yield Insights

Breakdown	TTM	12/28/2024	12/30/2023	12/31/2022	12/25/2021	12/26/2020
Revenue	4,023	4,049	4,129	3,976	3,540	2,923
Revenue Growth (YoY)	-1%	-2%	4%	12%	21%	12%
Cost of Revenue	2,628	2,642	2,600	2,513	2,205	1,850
Gross Profit	1,395	1,407	1,529	1,462	1,334	1,073
Selling, General & Admin	724	718	732	656	576	507
Research & Development	--	--	--	--	--	--
Operating Expenses	923	857	869	802	701	619
Other Non Operating Income (Expenses)	-14	-3	-27	10	-56	100
Pretax Income	-22	93	581	622	480	447
Income Tax Expense	57	67	100	130	81	81
Net Income	-83	10	474	486	390	364
Net Income Growth	-120%	-98%	-2%	25%	7%	44%
Shares Outstanding (Diluted)	49.42	51.62	51.45	51.3	51.42	50.6
Shares Change (YoY)	-4%	0%	0%	0%	2%	2%
EPS (Diluted)	-1.68	0.19	9.22	9.47	7.6	7.2
EPS Growth	-121%	-98%	-3%	25%	6%	42%
Free Cash Flow	543	501	365	294	532	380
Free Cash Flow Per Share	10.98	9.7	7.09	5.73	10.34	7.5
Gross Margin	34.67%	34.74%	37.03%	36.77%	37.68%	36.7%
Operating Margin	11.73%	13.58%	15.96%	16.57%	17.85%	15.53%
Profit Margin	-2.06%	0.24%	11.47%	12.22%	11.01%	12.45%
Free Cash Flow Margin	13.49%	12.37%	8.83%	7.39%	15.02%	13%
EBITDA	671	688	796	805	756	565
EBITDA Margin	16.67%	16.99%	19.27%	20.24%	21.35%	19.32%
D&A For EBITDA	199	138	137	146	124	111
EBIT	472	550	659	659	632	454
EBIT Margin	11.73%	13.58%	15.96%	16.57%	17.85%	15.53%
Effective Tax Rate	-259.09%	72.04%	17.21%	20.9%	16.87%	18.12%

Charles River Laboratories International Inc (CRL) Price